Welcome to LookChem.com Sign In|Join Free

CAS

  • or

21080-85-3

Post Buying Request

21080-85-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

21080-85-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 21080-85-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,1,0,8 and 0 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 21080-85:
(7*2)+(6*1)+(5*0)+(4*8)+(3*0)+(2*8)+(1*5)=73
73 % 10 = 3
So 21080-85-3 is a valid CAS Registry Number.

21080-85-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-cyclopropyl-1,2-oxazol-3-amine

1.2 Other means of identification

Product number -
Other names 3-Isoxazolamine,5-cyclopropyl

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:21080-85-3 SDS

21080-85-3Downstream Products

21080-85-3Relevant articles and documents

A reliable synthesis of 3-amino-5-alkyl and 5-amino-3-alkyl isoxazoles

Johnson, Leland,Powers, James,Ma, Fupeng,Jendza, Keith,Wang, Bing,Meredith, Erik,Mainolfi, Nello

, p. 171 - 173 (2013/03/13)

A reliable procedure that can be used to access a wide range of 3-amino-5-alkyl and 5-amino-3-alkyl isoxazoles was developed. Reaction temperature and pH were key factors that determined the regioselectivity of the two reactions.

Pyridyloxyindoles Inhibitors of VEGF-R2 and Use Thereof for Treatment of Disease

-

Page/Page column 62, (2010/06/22)

The invention relates to novel organic compounds of formula (I), and their use in the treatment of the animal or human body, to pharmaceutical compositions comprising a compound of formula I and to the use of a compound of formula I for the preparation of pharmaceutical compositions for use in the treatment of protein kinase dependent diseases, especially of proliferative diseases, such as in the treatment of tumour diseases and ocular neovascular diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 21080-85-3